Literature DB >> 24419145

microRNA-17~92 is a powerful cancer driver and a therapeutic target.

Hyun Yong Jin1, Maoyi Lai2, Changchun Xiao2.   

Abstract

Entities:  

Keywords:  MicroRNA; NFκB; PI3K; cancer; lymphoma; miR-17~92; therapeutics

Mesh：

Substances：

Year:  2014        PMID： 24419145      PMCID： PMC6317711          DOI： 10.4161/cc.27784

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  8 in total

1.  miR-17~92 cooperates with RB pathway mutations to promote retinoblastoma.

Authors:  Karina Conkrite; Maggie Sundby; Shizuo Mukai; J Michael Thomson; David Mu; Scott M Hammond; David MacPherson
Journal:  Genes Dev       Date:  2011-08-04       Impact factor: 11.361

2.  Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia.

Authors:  Konstantinos J Mavrakis; Andrew L Wolfe; Elisa Oricchio; Teresa Palomero; Kim de Keersmaecker; Katherine McJunkin; Johannes Zuber; Taneisha James; Aly A Khan; Christina S Leslie; Joel S Parker; Patrick J Paddison; Wayne Tam; Adolfo Ferrando; Hans-Guido Wendel
Journal:  Nat Cell Biol       Date:  2010-02-28       Impact factor: 28.824

3.  A microRNA polycistron as a potential human oncogene.

Authors:  Lin He; J Michael Thomson; Michael T Hemann; Eva Hernando-Monge; David Mu; Summer Goodson; Scott Powers; Carlos Cordon-Cardo; Scott W Lowe; Gregory J Hannon; Scott M Hammond
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

4.  miR-19 is a key oncogenic component of mir-17-92.

Authors:  Virginie Olive; Margaux J Bennett; James C Walker; Cong Ma; Iris Jiang; Carlos Cordon-Cardo; Qi-Jing Li; Scott W Lowe; Gregory J Hannon; Lin He
Journal:  Genes Dev       Date:  2009-12-15       Impact factor: 11.361

5.  Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas.

Authors:  Ping Mu; Yoon-Chi Han; Doron Betel; Evelyn Yao; Massimo Squatrito; Paul Ogrodowski; Elisa de Stanchina; Aleco D'Andrea; Chris Sander; Andrea Ventura
Journal:  Genes Dev       Date:  2009-12-15       Impact factor: 11.361

6.  Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.

Authors:  Roland Schmitz; Ryan M Young; Michele Ceribelli; Sameer Jhavar; Wenming Xiao; Meili Zhang; George Wright; Arthur L Shaffer; Daniel J Hodson; Eric Buras; Xuelu Liu; John Powell; Yandan Yang; Weihong Xu; Hong Zhao; Holger Kohlhammer; Andreas Rosenwald; Philip Kluin; Hans Konrad Müller-Hermelink; German Ott; Randy D Gascoyne; Joseph M Connors; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Martin D Ogwang; Steven J Reynolds; Richard I Fisher; Rita M Braziel; Raymond R Tubbs; James R Cook; Dennis D Weisenburger; Wing C Chan; Stefania Pittaluga; Wyndham Wilson; Thomas A Waldmann; Martin Rowe; Sam M Mbulaiteye; Alan B Rickinson; Louis M Staudt
Journal:  Nature       Date:  2012-08-12       Impact factor: 49.962

7.  MicroRNA-17~92 plays a causative role in lymphomagenesis by coordinating multiple oncogenic pathways.

Authors:  Hyun Yong Jin; Hiroyo Oda; Maoyi Lai; Rebecca L Skalsky; Kelly Bethel; Jovan Shepherd; Seung Goo Kang; Wen-Hsien Liu; Mohsen Sabouri-Ghomi; Bryan R Cullen; Klaus Rajewsky; Changchun Xiao
Journal:  EMBO J       Date:  2013-08-06       Impact factor: 11.598

8.  Synthetic lethality between Rb, p53 and Dicer or miR-17-92 in retinal progenitors suppresses retinoblastoma formation.

Authors:  David Nittner; Irina Lambertz; Frederic Clermont; Pieter Mestdagh; Corinna Köhler; Søren Jensby Nielsen; Aart Jochemsen; Frank Speleman; Jo Vandesompele; Michael A Dyer; Alexander Schramm; Johannes H Schulte; Jean-Christophe Marine
Journal:  Nat Cell Biol       Date:  2012-08-05       Impact factor: 28.824
  8 in total
  8 in total

1.  Blocking the maturation of OncomiRNAs using pri-miRNA-17∼92 aptamer in retinoblastoma.

Authors:  Nithya Subramanian; Jagat R Kanwar; Rupinder K Kanwar; Subramanian Krishnakumar
Journal:  Nucleic Acid Ther       Date:  2014-12-16       Impact factor: 5.486

2.  Transfection of microRNA Mimics Should Be Used with Caution.

Authors:  Hyun Yong Jin; Alicia Gonzalez-Martin; Ana V Miletic; Maoyi Lai; Sarah Knight; Mohsen Sabouri-Ghomi; Steven R Head; Matthew S Macauley; Robert C Rickert; Changchun Xiao
Journal:  Front Genet       Date:  2015-12-02       Impact factor: 4.599

3.  Upregulation of the miR-17-92 cluster and its two paraloga in osteosarcoma - reasons and consequences.

Authors:  Leila Arabi; Joël R Gsponer; Jan Smida; Michaela Nathrath; Valeria Perrina; Gernot Jundt; Christian Ruiz; Luca Quagliata; Daniel Baumhoer
Journal:  Genes Cancer       Date:  2014-04

4.  A childhood acute lymphoblastic leukemia genome-wide association study identifies novel sex-specific risk variants.

Authors:  Sandeep K Singh; Philip J Lupo; Michael E Scheurer; Anshul Saxena; Amy E Kennedy; Boubakari Ibrahimou; Manuel Alejandro Barbieri; Ken I Mills; Jacob L McCauley; Mehmet Fatih Okcu; Mehmet Tevfik Dorak
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

5.  Differential Sensitivity of Target Genes to Translational Repression by miR-17~92.

Authors:  Hyun Yong Jin; Hiroyo Oda; Pengda Chen; Chao Yang; Xiaojuan Zhou; Seung Goo Kang; Elizabeth Valentine; Jennifer M Kefauver; Lujian Liao; Yaoyang Zhang; Alicia Gonzalez-Martin; Jovan Shepherd; Gareth J Morgan; Tony S Mondala; Steven R Head; Pyeung-Hyeun Kim; Nengming Xiao; Guo Fu; Wen-Hsien Liu; Jiahuai Han; James R Williamson; Changchun Xiao
Journal:  PLoS Genet       Date:  2017-02-27       Impact factor: 5.917

Review 6.  Prognostic role of miR-17-92 family in human cancers: evaluation of multiple prognostic outcomes.

Authors:  Feifei Liu; Feng Zhang; Xiangyu Li; Qi Liu; Wei Liu; Peng Song; Ziying Qiu; Yu Dong; Hao Xiang
Journal:  Oncotarget       Date:  2017-07-08

7.  Therapeutic strategy with artificially-designed i-lncRNA targeting multiple oncogenic microRNAs exhibits effective antitumor activity in diffuse large B-cell lymphoma.

Authors:  Yinghan Su; Bin Sun; Xuejing Lin; Xinying Zhao; Weidan Ji; Miaoxia He; Haihua Qian; Xianmin Song; Jianmin Yang; Jianmin Wang; Jie Chen
Journal:  Oncotarget       Date:  2016-08-02

8.  Concurrent PI3K and NF-κB activation drives B-cell lymphomagenesis.

Authors:  H Y Jin; M Lai; J Shephard; C Xiao
Journal:  Leukemia       Date:  2016-07-25       Impact factor: 11.528
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.